Ronald Slovick, MD
Urology · Appleton, WINPI 1932163524
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,446 of the $5,091 with a category attached, or 67.7%. Medtronic accounts for 76.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $3,300 and has fallen 64.8% since, to $1,163 in 2025.
Across 56 payments — averaging $90.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Neotract Inc.$1K
- Boston Scientific$140
- Johnson & Johnson$33
What the payments were for
- Travel & lodging$3,44668%
- Food & beverage$1,64432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 42 | $3,888 |
| Neotract Inc. | 9 | $1,029 |
| Boston Scientific | 4 | $140 |
| Johnson & Johnson | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,091 in reported general payments places this provider in the 80th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 68 | $44,080 |
| Tamsulosin Hcl | 1,118 | $19,845 |
| Finasteride | 598 | $8,820 |
| Tolterodine Tartrate ErTolterodine Tartrate | 76 | $7,566 |
| Solifenacin Succinate | 131 | $6,327 |
| Trospium Chloride | 19 | $1,801 |
| Estradiol | 18 | $1,353 |
| Silodosin | 13 | $1,128 |
| Cephalexin | 175 | $754 |
| Desmopressin Acetate | 13 | $648 |
| Terazosin Hcl | 33 | $566 |
| Doxazosin Mesylate | 32 | $531 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $432 |
| ClopidogrelClopidogrel Bisulfate | 11 | $374 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 12 | $323 |
Paid to pharmacies, not to this prescriber.
Other urology in Appleton
- Dan GralnekMadison$142K
- Amy GuiseMilwaukee$106K
- Christopher ManakasMadison$87K
- Bahareh Alavi-DunnGreen Bay$62K
- Javier SantiagoMadison$57K
- Kevin FlynnNeenah$56K
- Margaret KnoedlerMadison$31K
- Jeremy ReesePleasant Prairie$27K
- Edwin AbelMadison$22K
- Christopher WalshWauwatosa$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.